PEG by Introducer Method Via EG Scan

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-08-31

Study Completion Date

2015-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Percutaneous endoscopic gastrostomy(PEG) by introducer method has been proven to be safe and easy to perform. However, it is limited by its need to be performed in an endoscopy unit. E.G. ScanTM is an new portable ultrathin endoscope, capable of being performed in any hospital setting and introduced via nasal approach. Our aim is to prove that PEG by introducer method via E.G. ScanTM is feasible and safe. This will allow PEG to be done at hospitals and medical facilities without endoscopic units.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Bedside Portable Endoscopy for the Esophageal Foreign Body

NCT03009383

Esophageal Foreign Body

COMPLETED NA

Role of Hemostatic Powder (Endo-clotTM) in Success and Prevention of Bleeding Within Gastric Cancer Patients With Bleeding

NCT02732483

Bleeding at Gastric Cancer

UNKNOWN PHASE2

G-POEM for Treatment of Refractory Gastroparesis

NCT02732821

Diabetic Gastroparesis Idiopathic Gastroparesis Gastroparesis Postoperative

COMPLETED

Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective Evaluation of Efficacy

NCT02927886

Gastroparesis

UNKNOWN PHASE3

L-Gastrectomy With the Intelligent Navigation 4K UHD 3D Endoscopic Imaging System

NCT04526483

Stomach Neoplasms

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dysphagia Aspiration Esophageal Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PEG insertion arm via EG Scan

Percutaneous endoscopic insertion of gastrostomy via visualization through E.G. ScanTM

Group Type EXPERIMENTAL

Percutaneous Endoscopic Gastrostomy

Intervention Type PROCEDURE

Percutaneous Endoscopic Gastrostomy by introducer method via visualization through E.G. ScanTM

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percutaneous Endoscopic Gastrostomy

Percutaneous Endoscopic Gastrostomy by introducer method via visualization through E.G. ScanTM

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Require percutaneous endoscopic gastrostomy placement due to inability to achieve oral feeding for at least one month

Exclusion Criteria

* Patients with esophageal ulcers or strictures
* Patients with prior esophageal/gastric surgery (excepting gastric wedge resection)
* Patients at high risk of gastric bleeding, mechanical ileus or gastrointestinal perforation
* Other patients in whom the study investigators consider unfit for inclusion

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No